Literature DB >> 16985618

Urothelial carcinoma in a man with hereditary nonpolyposis colon cancer.

Dean L Lenz, Lewis E Harpster.   

Abstract

Although most upper tract urothelial carcinomas are believed to be acquired, patients with hereditary nonpolyposis colon cancer (HNPCC) may have more than 20 times the risk of the normal population for these cancers. Certain mismatch repair mutations are now known to be associated with the disease. Screening and surveillance regimens are still evolving, but urinalysis, urine cytology, cystoscopy, and periodic upper tract imaging are the mainstays. HNPCC should be considered in any patient who develops an upper tract urothelial cancer or has a suggestive family history.

Entities:  

Year:  2003        PMID: 16985618      PMCID: PMC1472987     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  16 in total

1.  Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.

Authors:  F S Leach; J T Hsieh; K Molberg; M H Saboorian; J D McConnell; A I Sagalowsky
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

2.  Familial aggregation of urothelial carcinoma.

Authors:  A O Mahboubi; R C Ahlvin; E O Mahboubi
Journal:  J Urol       Date:  1981-11       Impact factor: 7.450

3.  Cancer risk in mutation carriers of DNA-mismatch-repair genes.

Authors:  M Aarnio; R Sankila; E Pukkala; R Salovaara; L A Aaltonen; A de la Chapelle; P Peltomäki; J P Mecklin; H J Järvinen
Journal:  Int J Cancer       Date:  1999-04-12       Impact factor: 7.396

4.  Familial occurrence of carcinoma of the ureter.

Authors:  C E Burkland; R H Juzek
Journal:  J Urol       Date:  1966-11       Impact factor: 7.450

Review 5.  Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects.

Authors:  A Bellacosa; M Genuardi; M Anti; A Viel; M Ponz de Leon
Journal:  Am J Med Genet       Date:  1996-04-24

Review 6.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.

Authors:  H T Lynch; T C Smyrk; P Watson; S J Lanspa; J F Lynch; P M Lynch; R J Cavalieri; C R Boland
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

7.  The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands.

Authors:  H F Vasen; G J Offerhaus; F C den Hartog Jager; F H Menko; F M Nagengast; G Griffioen; R B van Hogezand; A P Heintz
Journal:  Int J Cancer       Date:  1990-07-15       Impact factor: 7.396

8.  25 years of HNPCC.

Authors:  H T Lynch; J F Lynch
Journal:  Anticancer Res       Date:  1994 Jul-Aug       Impact factor: 2.480

Review 9.  The tumor spectrum in HNPCC.

Authors:  P Watson; H T Lynch
Journal:  Anticancer Res       Date:  1994 Jul-Aug       Impact factor: 2.480

10.  Familial transitional cell carcinoma of renal pelvis and upper ureter.

Authors:  S L Orphali; G W Shols; J Hagewood; H Tesluk; J M Palmer
Journal:  Urology       Date:  1986-05       Impact factor: 2.649

View more
  1 in total

1.  Extracolonic manifestations of lynch syndrome.

Authors:  Brian J Bansidhar
Journal:  Clin Colon Rectal Surg       Date:  2012-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.